BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12108089)

  • 1. [Comparative pharmacoeconomic evaluation of various approaches to antibacterial therapy of ventilator-associated pneumonia].
    Rudnov VA
    Antibiot Khimioter; 2001; 46(12):22-6. PubMed ID: 12108089
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia.
    Montero A; Corbella X; Ariza J
    Crit Care Med; 2003 Oct; 31(10):2557-9. PubMed ID: 14530770
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
    Alvarez Lerma F;
    Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoeconomic evaluation of nosocomial pneumonia treatment].
    Krysanova IS; Kulikov AIu
    Antibiot Khimioter; 2008; 53(1-2):33-8. PubMed ID: 18942391
    [No Abstract]   [Full Text] [Related]  

  • 5. Eight days vs 15 days of antibiotics for ventilator-associated pneumonia.
    Nicastri E
    JAMA; 2004 Feb; 291(7):820; author reply 820. PubMed ID: 14970057
    [No Abstract]   [Full Text] [Related]  

  • 6. What to learn from decision analysis of diagnosis and treatment of ventilator-associated pneumonia?
    Amin M; Hebert PC
    Am J Respir Crit Care Med; 2003 Nov; 168(9):1025-6. PubMed ID: 14581286
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy of ventilator-associated pneumonia: what more can we do to use less antibiotics?
    Niederman MS
    Crit Care Med; 2004 Nov; 32(11):2344-5. PubMed ID: 15640653
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.
    ;
    Am J Respir Crit Care Med; 2005 Feb; 171(4):388-416. PubMed ID: 15699079
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the cost-/effectiveness relationship of initial therapy with imipenem/cilastatin in nosocomial pneumonia. Group study].
    Rodloff AC; Laubenthal HJ; Bastian A; Bestehorn K; Büchele G; Gaus W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Apr; 31(3):172-80. PubMed ID: 8672620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
    Sieger B
    Crit Care Med; 1998 Aug; 26(8):1462-3. PubMed ID: 9710113
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ventilator-associated pneumonia and multiresistant bacteria].
    Heininger A; Unertl K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Rimmelé T; Poupelin JC; Saux MC; Chassard D; Allaouchiche B
    Intensive Care Med; 2004 May; 30(5):989-91. PubMed ID: 14985960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of nosocomial pneumonia: bronchial fibroscopy, protected brushing and/or bronchial lavage is not indispensable].
    Marquette CH
    Rev Pneumol Clin; 2001 Apr; 57(2):124-31. PubMed ID: 11353918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective decontamination of the digestive tract and ventilator-associated pneumonia (part 1).
    Silvestri L; Petros AJ; Viviani M; Rommes JH; van Saene HK
    Respir Care; 2006 Jan; 51(1):67-9; author reply 70-2. PubMed ID: 16425468
    [No Abstract]   [Full Text] [Related]  

  • 15. Taking charge of ventilator-associated pneumonia.
    Schleder BJ
    Nurs Manage; 2003 Aug; 34(8):27-32; quiz 33. PubMed ID: 12888729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Etiology and diagnosis of pneumonia in patients on artificial lung ventilation].
    Khrapov KN; Pavlova EA; Kolesnik AV; Eremenko EA
    Anesteziol Reanimatol; 2001; (4):60-2. PubMed ID: 11586637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
    Alvarez Lerma F;
    J Chemother; 2001 Feb; 13(1):70-81. PubMed ID: 11233804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial treatment of ventilator-associated pneumonia.
    Leblebicioglu H
    Am J Respir Crit Care Med; 2004 May; 169(10):1166; author reply 1166-7. PubMed ID: 15132964
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal use of antibiotics for intubation-associated pneumonia.
    Rello J; Diaz E
    Intensive Care Med; 2001 Feb; 27(2):337-9. PubMed ID: 11396275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.